Fox Chase Cancer Center FCCC — Philadelphia, Pennsylvania

Fox Chase Cancer Center FCCC is a clinical research site located in Philadelphia, Pennsylvania, United States 19111-2497.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Center FCCC has participated in 1 clinical trials.

Therapeutic areas: Dose Escalation, Safety, Preliminary Efficacy.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Center FCCC?

Fox Chase Cancer Center FCCC has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Center FCCC conducted?

Fox Chase Cancer Center FCCC has 1 clinical trials on record. Their work covers Dose Escalation, Safety, Preliminary Efficacy.

Is Fox Chase Cancer Center FCCC accredited by Crixeo Health?

Fox Chase Cancer Center FCCC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase Cancer Center FCCC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.